{"product_id":"sv108-delivery-human-nk-cell-targeted-lnp-kit","title":"SV108 Delivery  Human NK cell targeted LNP kit","description":"\u003cp class=\"MsoNormal\" align=\"center\"\u003e\u003cb\u003e\u003cspan\u003eHuman \u003c\/span\u003e\u003c\/b\u003e\u003cb\u003e\u003cspan\u003eNK cells\u003c\/span\u003e\u003c\/b\u003e\u003cspan\u003e \u003c\/span\u003e\u003cb\u003e\u003cspan\u003etargeted SV108 Delivery  Kit information and Supporting Data\u003c\/span\u003e\u003c\/b\u003e\u003c\/p\u003e\n\u003cp class=\"MsoNormal\" align=\"center\"\u003e \u003c\/p\u003e\n\u003cp class=\"MsoNormal\" align=\"center\"\u003e\u003cspan\u003eTable 1 \u003c\/span\u003e\u003cspan\u003eThe Characterizations of human NKp46\u003csup\u003e+\u003c\/sup\u003e NK cells targeted LNP-mRNA generated by \u003c\/span\u003e\u003cspan\u003eSV108 Delivery\u003csup\u003eTM\u003c\/sup\u003e Kit\u003c\/span\u003e\u003c\/p\u003e\n\u003ctable class=\"MsoNormalTable\" border=\"1\" cellspacing=\"0\" cellpadding=\"0\" width=\"725\" height=\"73\"\u003e\n\u003ctbody\u003e\n\u003ctr\u003e\n\u003ctd nowrap\u003e\n\u003cp class=\"MsoNormal\" align=\"center\"\u003e\u003cspan\u003e \u003c\/span\u003e\u003c\/p\u003e\n\u003c\/td\u003e\n\u003ctd nowrap\u003e\n\u003cp class=\"MsoNormal\" align=\"center\"\u003e\u003cspan\u003eEE (%)\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/td\u003e\n\u003ctd nowrap\u003e\n\u003cp class=\"MsoNormal\" align=\"center\"\u003e\u003cspan\u003eSize (nm)\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/td\u003e\n\u003ctd nowrap\u003e\n\u003cp class=\"MsoNormal\" align=\"center\"\u003e\u003cspan\u003ePDI\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003ctr\u003e\n\u003ctd nowrap\u003e\n\u003cp class=\"MsoNormal\" align=\"center\"\u003e\u003cspan\u003eSV108 Delivery\u003csup\u003eTM\u003c\/sup\u003e \u003c\/span\u003e\u003c\/p\u003e\n\u003c\/td\u003e\n\u003ctd nowrap\u003e\n\u003cp class=\"MsoNormal\" align=\"center\"\u003e\u003cspan\u003e97.8±2.1\u003c\/span\u003e\u003cspan\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/td\u003e\n\u003ctd nowrap\u003e\n\u003cp class=\"MsoNormal\" align=\"center\"\u003e\u003cspan\u003e125.8±3.0\u003c\/span\u003e\u003cspan\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/td\u003e\n\u003ctd nowrap\u003e\n\u003cp class=\"MsoNormal\" align=\"center\"\u003e\u003cspan\u003e0.17±0.03\u003c\/span\u003e\u003cspan\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003c\/td\u003e\n\u003c\/tr\u003e\n\u003c\/tbody\u003e\n\u003c\/table\u003e\n\u003cp class=\"MsoNormal\"\u003e \u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003e\u003cspan\u003eThe kit exhibits consistently high encapsulation efficiency (\u0026gt;95%), generate nanoparticles with a uniform average size of approximately 125 nm, and maintain a low polydispersity index (PDI). \u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003e \u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003e\u003cspan\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0759\/1804\/9537\/files\/Table1_SV108.png?v=1778249573\" alt=\"\" width=\"603\" height=\"224\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003e\u003cb\u003e\u003cspan\u003eFigure 1.\u003c\/span\u003e\u003c\/b\u003e\u003cspan\u003e Stability of human NKp46\u003csup\u003e+\u003c\/sup\u003e NK cells targeted LNP-mRNA generated by SV108 Delivery\u003csup\u003eTM\u003c\/sup\u003e Kit. The human NKp46\u003csup\u003e+\u003c\/sup\u003e NK cells targeted LNP-mRNA underwent three freeze–thaw cycles. Shown are nanoparticle size (left), polydispersity index (PDI) (right).  \u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003e\u003cspan\u003e\u003cimg src=\"https:\/\/cdn.shopify.com\/s\/files\/1\/0759\/1804\/9537\/files\/Figure2_SV108.png?v=1778250429\" alt=\"\"\u003e\u003c\/span\u003e\u003c\/p\u003e\n\u003cp class=\"MsoNormal\"\u003e\u003cb\u003e\u003cspan\u003eFigure 2.\u003c\/span\u003e\u003c\/b\u003e\u003cspan\u003e \u003c\/span\u003e\u003cspan\u003eThe SV108 Delivery\u003csup\u003eTM \u003c\/sup\u003ekit demonstrated strong transfection efficacy and cell type specificity in human NK cells. \u003ci\u003eIn vitro \u003c\/i\u003etransfection efficacy: human NK cells were transfected with mRNA encoding eGFP using SV108 Delivery\u003csup\u003eTM\u003c\/sup\u003e kit as indicated. Shown are FACS plots (A) and GFP\u003csup\u003e+\u003c\/sup\u003e cells percentage (B) one day post-transfection determined by flow cytometer.\u003c\/span\u003e\u003c\/p\u003e","brand":"SunVax mRNA Therapeutics","offers":[{"title":"SV108 Delivery Human NK cell for delivery of 36 μg mRNA","offer_id":55184286318871,"sku":null,"price":639.0,"currency_code":"USD","in_stock":true},{"title":"SV108 Delivery Human NK cell  for delivery of 216 μg mRNA","offer_id":55184286351639,"sku":null,"price":1439.0,"currency_code":"USD","in_stock":true}],"url":"https:\/\/apenzybio.com\/products\/sv108-delivery-human-nk-cell-targeted-lnp-kit","provider":"Apenzy Biosciences","version":"1.0","type":"link"}